Published in Obesity and Diabetes Week, March 5th, 2007
On 15 January, Novo Nordisk announced a decision to focus all its research and development resources on the company's growing pipeline of protein-based...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.